久久亚洲国产成人影院-久久亚洲国产的中文-久久亚洲国产高清-久久亚洲国产精品-亚洲图片偷拍自拍-亚洲图色视频

Global EditionASIA 中文雙語Fran?ais
China
Home / China / Latest

Rapidly developed coronavirus vaccine set for testing

By AI HEPING in New York | China Daily Global | Updated: 2020-02-27 01:39
Share
Share - WeChat

A rapidly developed coronavirus vaccine will be tested on healthy volunteers in the US in April, the director of the National Institute of Allergy and Infectious Diseases (NIAID) said Tuesday.

The vaccine, by drugmaker Moderna and NIAID, will be tested on 20 to 25 humans to determine whether two doses will be safe and generate an immune response to protect against infection, with results available in July or August, NIAID's Dr Anthony Fauci told The Wall Street Journal.

NIAID is part of the National Institutes of Health (NIH), an agency of the US Department of Health and Human Services. The Coalition for Epidemic Preparedness Innovations (CEPI), an international funding body, is also backing the effort.

Also on Tuesday, NIH announced that the first clinical trial testing of Gilead Sciences' antiviral drug remdesivir in a hospitalized patient with the coronavirus has started, according to Reuters.

The participant is an American who was repatriated after being quarantined in Japan aboard the cruise ship Diamond Princess and is being conducted at the University of Nebraska Medical Center in Omaha, NIH said.

The World Health Organization (WHO) said Monday that remdesivir is showing signs of helping to treat the coronavirus.

A successful trial of Moderna's vaccine — mRNA-1273 — would be followed by further studies and regulatory hurdles, Fauci said, meaning a coronavirus vaccine would not be ready for widespread distribution until at least next year.

Moderna said the vaccine was developed after obtaining genetic information on the coronavirus from China.

Referring to the speed of the drug's development and expected clinical trial, Fauci said it is "unquestionably the world indoor record. Nothing has ever gone that fast."

However, it's uncertain whether the drug will work, considering that the gene-based technology it uses hasn't yet resulted in an approved human vaccine.

Even if it isn't ready for widespread distribution until next year, Fauci told the newspaper that it's possible the spread of the coronavirus could lessen during warmer months but return next winter and become a seasonal virus like the flu.

"The only way you can completely suppress an emerging infectious disease is with a vaccine," he said. "If you want to really get it quickly, you're using technologies that are not as time-honored as the standard — what I call antiquated — way of doing it."

Moderna was founded in 2010 to develop drugs and vaccines. In 2018 it opened a manufacturing site in Norwood, Massachusetts, near the company's Cambridge headquarters. The company is targeting cancer, heart disease and infectious diseases. It hasn't brought any drugs or vaccines to market.

The first trial will be conducted at NIAID's clinical trials unit in Bethesda, Maryland, where the agency is based. If the first one is successful, a second trial of hundreds or thousands of participants could begin, which could take six to eight months, he said.

That trial could be conducted partly in the US but also in other regions where the virus is spreading, so the testing could gauge whether the vaccine reduces infection rates.

If the second trial is positive, the vaccine could be ready for widespread use, Fauci said. How widely the virus has spread by then will determine whether it is given to targeted groups, such as healthcare workers, or more broadly to the general population, he said.

Health officials and pharmaceutical companies around the world are racing to identify treatments or a vaccine to help fight the coronavirus, which has infected more than 80,000 people around the world.

Johnson & Johnson, GlaxoSmithKline?and Gilead are among the drugmakers working on vaccines, as are government scientists, including some at NIAID.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 97在线观看免费版 | 天堂8中文在线最新版在线 天堂8资源8在线 | 在线欧美 | 91视频99| 美女一级片视频 | 亚洲精品福利一区二区三区 | 国产香蕉在线视频一级毛片 | 中文字幕一区二区在线播放 | 免费人成黄页网站在线观看国产 | 久久久国产精品福利免费 | 精品久久久久久久久久香蕉 | 日本精品一在线观看视频 | 欧美xxxxx九色视频免费观看 | 欧美一级毛片免费播放器 | 久久精品99毛片免费 | 欧美成人高清手机在线视频 | 国产成人精品三级 | 俄罗斯特级毛片 | 久久综合九九亚洲一区 | 一级特色黄大片 | 最新亚洲人成网站在线影院 | 国产妇乱子伦视频免费 | 日韩成人免费在线 | 一级特级aaa毛片 | 日本美女视频韩国视频网站免费 | 在线视频 国产交换 | 免费一级欧美大片久久网 | 久久伊人精品热在75 | 日本一线a视频免费观看 | 毛片一区二区三区 | 成人永久免费视频 | 亚洲日本免费 | www看片| 三级黄色片在线免费观看 | 日本aaaa片毛片免费观看 | 特级a级毛片 | 亚洲欧洲日产国码一级毛片 | 一级特黄aa大片欧美 | 国产精品成人久久久久久久 | 国产原创自拍 | 亚洲视频免费一区 |